Clinical Trial: ADO-5030 in Bronchoconstriction Challenge, Phase 1b

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281274) titled 'ADO-5030 in Bronchoconstriction Challenge, Phase 1b' on Nov. 17.

Brief Summary: The goal of this clinical trial is to learn if ADO-5030 reduces asthma symptoms during a respiratory challenge in adults with mild to moderate asthma. It will also learn about the safety and tolerability of ADO-5030 in asthmatics. The main questions it aims to answer are:

* Does ADO-5030 reduce asthma symptoms during the respiratory challenge?

* Is ADO-5030 safe and tolerable for adults with mild to moderate asthma?

Participants will:

* Visit the clinic 3 or 4 times.

* Undergo 2 or 3 respiratory challenges.

* Be given a single oral dose of ADO-5030...